TY - JOUR
T1 - Uveitic Glaucoma
T2 - Long-term Clinical Outcome and Risk Factors for Progression
AU - Sharon, Yael
AU - Friling, Ronit
AU - Luski, Moshe
AU - Campoverde, Belén Quizhpe
AU - Amer, Radgonde
AU - Kramer, Michal
N1 - Publisher Copyright:
© Taylor & Francis Group, LLC.
PY - 2017/11/2
Y1 - 2017/11/2
N2 - Purpose: To study the long-term clinical outcomes of uveitic glaucoma and to identify risk factors for progression. Methods: Retrospective study of uveitic glaucoma patients in two tertiary medical centers in 2003–2015. Patient- and disease-related data was retrieved. Clinical parameters and visual fields measured at predetermined time points were recorded. Outcome measures included maintaining intraocular pressure ≤21 mmHg and preserving visual fields. Results: Included were 34 patients (53 eyes), with a mean follow-up of 7 years. Idiopathic anterior uveitis and open-angle glaucoma were most common. In total, 62% of eyes were steroid responders. Higher IOP was associated with posterior synechiae, peripheral-anterior synechiae, steroidal, and immunomodulatory therapy (p<0.05). Glaucomatous field defects developed in 49%, with most showing no progression, despite elevation of cup-to-disc ratio (p<0.05). Conclusions: Chronic severe uveitis, expressed by structural complications and immunomodulatory therapy, was associated with high IOP and the need for more IOP lowering medications, but was unrelated to glaucomatous damage.
AB - Purpose: To study the long-term clinical outcomes of uveitic glaucoma and to identify risk factors for progression. Methods: Retrospective study of uveitic glaucoma patients in two tertiary medical centers in 2003–2015. Patient- and disease-related data was retrieved. Clinical parameters and visual fields measured at predetermined time points were recorded. Outcome measures included maintaining intraocular pressure ≤21 mmHg and preserving visual fields. Results: Included were 34 patients (53 eyes), with a mean follow-up of 7 years. Idiopathic anterior uveitis and open-angle glaucoma were most common. In total, 62% of eyes were steroid responders. Higher IOP was associated with posterior synechiae, peripheral-anterior synechiae, steroidal, and immunomodulatory therapy (p<0.05). Glaucomatous field defects developed in 49%, with most showing no progression, despite elevation of cup-to-disc ratio (p<0.05). Conclusions: Chronic severe uveitis, expressed by structural complications and immunomodulatory therapy, was associated with high IOP and the need for more IOP lowering medications, but was unrelated to glaucomatous damage.
KW - Clinical outcome
KW - risk factors
KW - secondary glaucoma
KW - uveitis
KW - visual field
UR - http://www.scopus.com/inward/record.url?scp=85004011485&partnerID=8YFLogxK
U2 - 10.1080/09273948.2016.1255341
DO - 10.1080/09273948.2016.1255341
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27937076
AN - SCOPUS:85004011485
SN - 0927-3948
VL - 25
SP - 740
EP - 747
JO - Ocular Immunology and Inflammation
JF - Ocular Immunology and Inflammation
IS - 6
ER -